Previously, we constructed two sorafenib-resistant cell lines (Huh7 and HepG2),17 the results showed that Sema3C expression was significantly increased in sorafenib-resistant HCC cells (Fig. 1g). This evidence concerns the gene SEMA3C and hepatocellular carcinoma.